拉斯维加斯9888

Latest news

3SBio Unveils 2024 Interim Results: Revenue Up 16% YoY, Autoimmune Pipeline Poised for a Promising Phase

2024-03-20 / News

3SBio reveals 2023 annual results: Revenue surges by 13.8% year on year, with pipelines to reap the rewards

3SBio will remain steadfast in its role as a national biopharmaceutica...

• 

  2023-03-21 / News

  3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%

  3SBio is committed to sharpening its focus on refined management and e...

• 

  2022-08-24 / News

  3SBio announces 2022 interim results, with net profit attributable to owners of the parents continuing to grow despite COVID-19 and cash hitting new record high

  with net profit attributable to owners of the parents continuing to gr...

• 

  2022-03-30 / News

  3SBio announces 2021 annual results, with net profit attributable to owns of the parents almost doubling under accelerated growth of diversified businesses

  3SBio announces 2021 annual results

View more